EHSRC Role(s): Co-Leader, Inflammation and Innate Immunity Thematic Area
Dr. McCray has a long-standing interest in the pathogenesis and treatment of cystic fibrosis. His laboratory has two main areas of investigation: 1) pulmonary host defense, and 2) gene transfer for the treatment of inherited diseases. Work in the lab is supported by the NIH and the Cystic Fibrosis Foundation.
Selected Publications: